Abingdon Health Plc provided earnings guidance for the full year 2022. for the year, the company expects The trading performance was disappointing, revenues are expected to be in the region of £2.8 million (FY21: £11.6 million (£3.6 million excluding DHSC revenue and a one off COVID customer order)) and a substantial loss for the year will be incurred. A significant proportion of these losses relate to the increase in operational infrastructure related to AbC-19™ and the DHSC contract and the subsequent unwinding of this investment.

As part of this, the Company further restructured its operations early in Fourth Quarter FY22 with a reduction in headcount from 123 employees at the end of December 2021 to 86 employees at the end of July which, along with other cost saving measures implemented, has significantly reduced the ongoing monthly operational cash outflow.